Ouk T - Search Results

1

[Cerebral ischaemia: tomorrow's therapeutic tracks].

Bordet R, Ouk T, Onténiente B, Charriaut-Marlangue C, Heurteaux C. Bordet R, et al. Among authors: ouk t. Med Sci (Paris). 2009 Oct;25(10):847-54. doi: 10.1051/medsci/20092510847. Med Sci (Paris). 2009. PMID: 19849988 Free article. Review. French.

2

Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion.

Pétrault O, Ouk T, Gautier S, Laprais M, Gelé P, Bastide M, Bordet R. Pétrault O, et al. Among authors: ouk t. Br J Pharmacol. 2005 Apr;144(8):1051-8. doi: 10.1038/sj.bjp.0706124. Br J Pharmacol. 2005. PMID: 15700030 Free PMC article.

3

Changes in cerebral vascular reactivity occur early during cardiopulmonary bypass in the rat.

Modine T, Azzaoui R, Ouk T, Fayad G, Lacroix D, Warembourg H, Bordet R, Gourlay T. Modine T, et al. Among authors: ouk t. Ann Thorac Surg. 2006 Aug;82(2):672-8. doi: 10.1016/j.athoracsur.2006.03.061. Ann Thorac Surg. 2006. PMID: 16863783

4

Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.

Gautier S, Ouk T, Petrault O, Caron J, Bordet R. Gautier S, et al. Among authors: ouk t. Br J Pharmacol. 2009 Feb;156(4):673-9. doi: 10.1111/j.1476-5381.2009.00068.x. Epub 2009 Feb 4. Br J Pharmacol. 2009. PMID: 19210512 Free PMC article.

5

Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection.

Ouk T, Laprais M, Bastide M, Mostafa K, Gautier S, Bordet R. Ouk T, et al. Vascul Pharmacol. 2009 Nov-Dec;51(5-6):323-30. doi: 10.1016/j.vph.2009.08.002. Epub 2009 Sep 2. Vascul Pharmacol. 2009. PMID: 19732852

6

PPARs: a potential target for a disease-modifying strategy in stroke.

Ouk T, Potey C, Gautier S, Bastide M, Deplanque D, Staels B, Duriez P, Leys D, Bordet R. Ouk T, et al. Curr Drug Targets. 2013 Jun;14(7):752-67. doi: 10.2174/1389450111314070005. Curr Drug Targets. 2013. PMID: 23514380 Review.

7

PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke.

Ouk T, Potey C, Laprais M, Gautier S, Hanf R, Darteil R, Staels B, Duriez P, Bordet R. Ouk T, et al. Fundam Clin Pharmacol. 2014 Jun;28(3):294-302. doi: 10.1111/fcp.12035. Epub 2013 May 23. Fundam Clin Pharmacol. 2014. PMID: 23701370

8

Time-induced progressive alteration of kir current in cerebral smooth muscle cells of stroke-prone spontaneously hypertensive rats.

Bastide M, Ouk T, Pétrault O, Bordet R. Bastide M, et al. Among authors: ouk t. Int J Hypertens. 2013;2013:849750. doi: 10.1155/2013/849750. Epub 2013 Apr 23. Int J Hypertens. 2013. PMID: 23710341 Free PMC article.

9

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.

Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destée A, Duhamel A, Bordet R, Defebvre L, Dujardin K. Devos D, et al. Among authors: ouk t. J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74. doi: 10.1136/jnnp-2013-306439. Epub 2013 Nov 11. J Neurol Neurosurg Psychiatry. 2014. PMID: 24218528 Clinical Trial.

10

Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia.

Ouk T, Gautier S, Pétrault M, Montaigne D, Maréchal X, Masse I, Devedjian JC, Deplanque D, Bastide M, Nevière R, Duriez P, Staels B, Pasquier F, Leys D, Bordet R. Ouk T, et al. J Cereb Blood Flow Metab. 2014 Mar;34(3):542-51. doi: 10.1038/jcbfm.2013.233. Epub 2014 Jan 8. J Cereb Blood Flow Metab. 2014. PMID: 24398933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page